Control of gut differentiation and intestinal-type gastric carcinogenesis

Nature Reviews Cancer

Volumn 3, Issue 8, 2003, Pages 592-600

  Yuasa, Yasuhito ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; DNA; HELIX LOOP HELIX PROTEIN; HOMEODOMAIN PROTEIN; INTESTINAL TREFOIL FACTOR; NEUROGENIN 3; SCATTER FACTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CDX1; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG;

ANIMAL MODEL; ATROPHIC GASTRITIS; CHRONIC GASTRITIS; GENE MUTATION; GENETIC TRANSCRIPTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; MICROSATELLITE INSTABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH CARCINOGENESIS; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; CARCINOMA; CELL DIFFERENTIATION; CLASSIFICATION; HELICOBACTER INFECTION; METABOLISM; METAPLASIA; PATHOLOGY; PRENATAL DEVELOPMENT; STOMACH; STOMACH MUCOSA; STOMACH TUMOR;

ANIMALS; CARCINOMA; CELL DIFFERENTIATION; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METAPLASIA; MODELS, BIOLOGICAL; STOMACH; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0042886962     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1141     Document Type: Review

References (98)

1. Pisani, P., Parkin, D. M., Bray, F. & Ferlay, J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 83, 870-873 (1999).
2. Food, Nutrition and the Prevention of Cancer: a Global Perspective (eds Potter, J. D. et al.) (World Cancer Research Fund/American Institute for Cancer Research, 1997).
3. Peek R. M. Jr & Blaser, M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature Rev. Cancer 2, 28-37 (2002).
4. Huang, J. Q., Sridhar, S., Chen, Y. & Hunt, R. H. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114, 1169-1179 (1998). Meta-analysis of the relationship between H. pylori infection and gastric cancer shows that infection with these bacteria is equally associated with the intestinal or diffuse types of gastric cancer.
5. Lauren, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand. 64, 31-49 (1965).
6. Correa, P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention Cancer Res. 52, 6735-6740 (1992).
7. Abate-Shen, C. Deregulated homeobox gene expression in cancer: cause or consequence? Nature Rev. Cancer 2, 777-785 (2002). Proposes that homeobox genes can be defined as tumour modulators rather than as oncogenes or tumour suppressors, based on deregulated gene expression in cancer.
8. Grapin-Botton, A. & Melton D. A. Endoderm development: from patterning to organogenesis. Trends Genet. 16, 124-130 (2000).
9. Kuo, C. T. et al. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 11, 1048-1060 (1997).
10. Molkentin, J. D., Lin, Q., Duncan, S. A. & Olson, E. N. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 11, 1061-1072 (1997).
11. Solloway, M. J. & Robertson, E. J. Early embryonic lethality in Bmp5; Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development 126, 1753-1768 (1999).
12. Beck, F., Tata, F. & Chawengsaksophak, K. Homeobox genes and gut development. Bioessays 22, 431-441 (2000).
13. Kawazoe, Y. et al. Region-specific gastrointestinal Hox code during murine embryonal gut development. Dev Growth Differ. 44, 77-84 (2002).
14. Roberts, D. J. et al. Sonic hedgehog is an endodermal signal inducing Bmp-4 and Hox genes during induction and regionalization of the chick hindgut. Development 121, 3163-3174 (1995).
15. Roberts, D. J., Smith, D. M., Goff, D. J. & Tabin, C. J. Epithelial-mesenchymal signaling during the regionalization of the chick gut. Development 125, 2791-2801 (1998).
16. Silberg, D. G., Swain, G. P., Suh, E. R. & Traber, P. G. Cdx1 and Cdx2 expression during intestinal development. Gastroenterology 119, 961-971 (2000).
17. Offield, M. F. et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122, 983-995 (1996).
18. Chawengsaksophak, K., James, R., Hammond, V. E., Kontgen, F. & Beck, F. Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 386, 84-87 (1997). Mice with heterozygous disruptions in Cdx2 develop many colonic polyps, indicating a tumour-suppressive activity of Cdx2.
19. Beck, F., Chawengsaksophak, K,. Waring, P., Playford, R. J. & Furness, J. B. Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc. Natl Acad. Sci. USA 96, 7318-7323 (1999).
20. Lorentz, O. et al. Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation. J. Cell Biol. 139, 1553-1565 (1997).
21. Charite, J. et al. Transducing positional information to the Hox genes: critical interaction of Cdx gene products with position-sensitive regulatory elements. Development 125, 4349-4358 (1998).
22. Subramanian, V., Meyer, B. I. & Gruss, P. Disruption of the murine homeobox gene Cdx1 affects axial skeletal identities by altering the mesodermal expression domains of Hox genes. Cell 83, 641-653 (1995).
23. Jonsson, J., Carlsson, L., Edlund, T. & Edlund, H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371, 606-609 (1994).
24. Lickert, H., Kispert, A., Kutsch, S. & Kemler, R. Expression patterns of Wnt genes in mouse gut development. Mech. Dev. 105, 181-184 (2001).
25. McBride, H. J., Fatke, B. & Fraser, S. E. Wnt signaling components in the chicken intestinal tract. Dev. Biol. 256, 18-33 (2003).
26. Wells, J. M. & Melton, D. A. Early mouse endoderm is patterned by soluble factors from adjacent germ layers. Development 127, 1563-1572 (2000).
27. Ishii, Y., Rex, M., Scotting, P. J. & Yasugi, S. Region-specific expression of chicken Sox2 in the developing gut and lung epithelium: regulation by epithelial-mesenchymal interactions. Dev. Dyn. 213, 464-475 (1998).
28. Miettinen, P. J. et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376, 337-341 (1995).
29. Pabst, O., Zweigerdt, R, & Arnold, H, H. Targeted disruption of the homeobox transcription factor Nkx2-3 in mice results in postnatal lethality and abnormal development of small intestine and spleen. Development 126, 2215-2225 (1999).
30. Sakamoto, N. et al. Role for cGATA-5 in transcriptional regulation of the embryonic chicken pepsinogen gene by epithelial-mesenchymal interactions in the developing chicken stomach Dev. Biol. 223, 103-113 (2000).
31. Nishi, T., Kubo, K., Hasebe, M., Maeda, M. & Futai, M. Transcriptional activation of H+/K+-ATPase genes by gastric GATA binding proteins. J. Biochem. 121, 922-929 (1997).
32. Jacobsen, C. M. et al. Genetic mosaic analysis reveals that GATA-4 is required for proper differentiation of mouse gastric epithelium. Dev. Biol. 241, 34-46 (2002).
33. Larsson, L. I., Madsen, O. D., Serup, P., Jonsson, J. & Edlund, H. Pancreatic-duodenal homeobox 1: role in gastric endocrine patterning. Mech. Dev. 60, 175-184 (1996).
34. Freund, J. N., Domon-Dell, C., Kedinger, M. & Duluc, I. The Cdx-1 and Cdx-2 homeobox genes in the intestine. Biochem. Cell Biol. 76, 957-969 (1998).
35. Yamamoto, H., Bai, Y.-Q. & Yuasa, Y. Homeodomain protein CDX2 regulates goblet specific MUC2 gene expression. Biochem. Biophys. Res. Commun. 300, 813-818 (2003).
36. Hinoi, T. et al. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 122, 1565-1577 (2002).
37. Jensen, J. et al Control of endodermal endocrine development by Hes-1. Nature Genet. 24, 36-44 (2000)
38. Yang, Q., Bermingham, N. A. Finegold, M. J. & Zoghbi, H. Y. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 294, 2155-2158 (2001).
39. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49, 347-353 (2001).
40. Higashi, H. et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295, 683-686 (2002).
41. Hussain, S. P., Hofseth, L. J. & Harris, C. C. Radical causes of cancer. Nature Rev. Cancer 3, 276-285 (2003).
42. El-Omar, E. M. et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398-402 (2000). Shows that the IL-1β polymorphism can determine why some individuals infected with H. pylori develop gastric cancer but others do not.
43. Bai, Y.-Q., Miyake, S., Iwai, T. & Yuasa, Y. CDX2, a homeobox transcription factor up-regulates transcription of the p21/WAF1/CIP1 gene. Oncogene (in the press).
44. Bai, Y.-Q. et al. Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett. 176, 47-55 (2002). The expression of the intestine-specific homeoprotein CDX2 was found in intestinal metaplasia and carcinomas of the stomach, indicating its involvement in these lesions.
45. Silberg, D. G. et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 122, 689-696 (2002). Cdx2 ectopic expression in the stomach induces intestinal metaplasia in transgenic mice, showing that Cdx2 is involved in the initiation of intestinal metaplasia formation.
46. Ishii, Y., Fukuda, K., Saiga, H., Matsushita, S. & Yasugi, S. Early specification of intestinal epithelium in the chicken embryo: a study on the localization and regulation of CdxA expression. Dev. Growth Differ. 39, 643-653 (1997).
47. Xu, F., Li, H. & Jin, T. Cell type-specific autoregulation of the caudal-related homeobox gene Cdx-2/3. J. Biol. Chem. 274, 34310-34316 (1999).
48. Silberg, D. G. et al. CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology 113, 478-486 (1997).
49. Ruiz I Altaba, A., Sanchez, P. & Dahmane, N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nature Rev. Cancer 2, 361-372 (2002).
50. Ramalho-Santos, M., Melton, D. A. & McMahon, A. P. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development 127, 2763-2772 (2000).
51. van den Brink, G. R. et al. Sonic hedgehog expression correlates with fundic gland differentiation in the adult gastrointestinal tract. Gut 51, 628-633 (2002).
52. Lee, C. S., Perreault, N., Brestelli, J. E. & Kaestner, K. H. Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev. 16, 1488-1497 (2002).
53. Taupin, D. et al. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium. Lab. Invest. 81, 397-408 (2001).
54. Suh, E. & Traber, P. G. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol. Cell. Biol. 16, 619-625 (1996).
55. Mallo, G. V. et al. Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells. J. Biol. Chem. 273, 14030-14036 (1998).
56. Ee, H. C., Erler, T., Bhathal, P. S., Young, G. P. & James, R. J. Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am. J. Pathol. 147, 586-592 (1995).
57. Mallo, G. V. et al. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int. J. Cancer 74, 35-44 (1997).
58. Soubeyran, P. et al. Cdx1 promotes differentiation in a rat intestinal epithelial cell line. Gastroenterology 117, 1326-1338 (1999).
59. Lorentz, O. et al. Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras. Oncogene 18, 87-92 (1999).
60. Lickert, H. et al. Wnt/β-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine. Development 127, 3805-3813 (2000).
61. Lynch, J. et al. The caudal-related homeodomain protein Cdx1 inhibits proliferation of intestinal epithelial cells by down-regulation of D-type cyclins. J. Biol. Chem. 275, 4499-4506 (2000).
62. Kuniyasu, H., Yasui, W., Yokozaki, H. & Tahara, E. Helicobacter pylori infection and carcinogenesis of the stomach. Langenbecks Arch. Surg. 385, 69-74 (2000).
63. Lee, J. H. et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma Am. J. Pathol. 161, 611-618 (2002).
64. Kinzler K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996).
65. Nakatsuru, S. et al. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum. Mol. Genet. 1, 559-563 (1992).
66. Tamura, G. et al. Mutations of the APC gene occur during early stages of gastric adenoma development. Cancer Res. 54, 1149-1151 (1994).
67. Seidensticker, M. J. & Behrens, J. Biochemical interactions in the wnt pathway. Biochim. Biophys. Acta 1495, 168-182 (2000).
68. Park, W. S. et al. Frequent somatic mutations of the β-catenin gene in intestinal-type gastric cancer. Cancer Res. 59, 4257-4260 (1999).
69. Dunker, N. & Krieglstein, K. Targeted mutations of transforming growth factor-β genes reveal important roles in mouse development and adult homeostasis. Eur. J. Biochem. 267, 6982-6988 (2000).
70. Boivin, G. P., Molina, J. R., Ormsby I., Stemmermann, G. & Doetschman, T. Gastric lesions in transforming growth factor β-1 heterozygous mice. Lab. Invest. 74, 513-518 (1996).
71. Park, K. et al. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl Acad. Sci. USA 91, 8772-8776 (1994).
72. Wu, M. S. et al. Clinicopathological significance of altered loci of replication error and microsatellite instability-associated mutations in gastric cancer. Cancer Res. 58, 1494-1497 (1998).
73. Suzuki, H. et al. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int. J. Cancer 83, 309-313 (1999).
74. Iacopetta, B. J., Soong, R., House, A. K. & Hamelin, R. Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-β type II receptor, IGFII receptor, and BAX genes. J. Pathol. 187, 428-432 (1999).
75. Schneider, B. G. et al. Microsatellite instability, prognosis and metastasis in gastric cancers from a low-risk population. Int. J. Cancer 89, 444-452 (2000).
76. Markowitz, S. et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338 (1995).
77. Parsons, R. et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res. 55, 5548-5550 (1995).
78. Li, Q. L. et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109, 113-124 (2002).
79. Kim, J. H. et al. Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J. Natl Cancer Inst. 83, 938-943 (1991).
80. Tamura, G. et al. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res. 51, 3056-3058 (1991).
81. Hamilton, S. R. & Smith, R. R. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am. J. Clin. Pathol. 87, 301-312 (1987).
82. Marchetti, M., Caliot, E. & Pringault, E. Chronic acid exposure leads to activation of the Cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes. J. Cell Sci. 116, 1429-1436 (2003). Shows that chronic acid exposure leads to activation of Cdx2 expression in mouse oesophageal keratinocytes.
83. Kozuka, S., Kurashina, M., Tsubone, M., Hachisuka, K. & Yasui, A. Significance of intestinal metaplasia for the evolution of cancer in the biliary tract. Cancer 54, 2277-2285 (1984).
84. Parkin, D. M., Ohshima, H., Srivatanakul, P. & Vatanasapt, V. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol. Biomarkers Prev. 2, 537-544 (1993).
85. Albores-Saavedra, J., Nadji, M. & Henson, D. E. Intestinal-type adenocarcinoma of the gallbladder. A clinicopathologic study of seven cases. Am. J. Surg. Pathol. 10, 19-25 (1986).
86. Fox, J. G. et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114, 755-763 (1998).
87. Eda, A. et al. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J. Gastroenterol. 38, 14-22 (2003).
88. Kim, S. et al. PTEN and TNF-α regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-κB-dependent pathway. Gastroenterology 23, 1163-1178 (2002). Shows that CDX2 is a target of PTEN/ phosphatidylinositol 3-kinase signalling and tumour necrosis factor-α.
89. Domon-Dell, C. & Freund, J. N. Stimulation of Cdx1 by oncogenic β-catenin/-Tcf4 in colon cancer cells; opposite effect of the CDX2 homeoprotein. FEBS Lett. 518, 83-87 (2002).
90. Correa, P. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy J. Natl. Cancer Inst. 92, 1881-1888 (2000).
91. Satoh, K. et al. Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori. Helicobacter 7, 192-198 (2002).
92. INK4a and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res. 61, 3419-3424 (2001).
93. Huang, M. E. et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567-572 (1988).
94. Jones, P. A. & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nature Rev. Genet. 3, 415-428 (2002).
95. Oda, T. et al. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl Acad. Sci. USA 91, 1858-1862 (1994).
96. Yoshiura, K. et al. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl Acad. Sci. USA 92, 7416-7419 (1995).
97. Guilford, P. et al. E-cadherin germline mutations in familial gastric cancer. Nature 392, 402-405 (1998). First presentation of germline mutations in E-cadherin in hereditary diffuse gastric carcinoma.
98. Thiery, J. P. et al. Epithelial-mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442-454 (2002).